rubeola (measles) gamma globulin (human)
Trade name: Gamastan
Biologicalapproved
Approved
May 14, 1944
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1940s
- May 14, 1944
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Measles virusImmunity, passive
Measles virus immunity, passive
Approval history
- approvedMay 14, 1944
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rubeola (measles) gamma globulin (human)